In a proteomics screen for tyrosine kinase variants, multiple brain and hematopoietic cancer cell lines harbored an inactivating TYK2 splice variant, E971fsX67 [15]. This evidence concerns the gene TYK2 and hematopoietic and lymphoid cell neoplasm.